trending Market Intelligence /marketintelligence/en/news-insights/trending/9H0C_OVTBOJIRKxu72LCdw2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Organovo expands board with addition of new director

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


Organovo expands board with addition of new director

Organovo Holdings Inc. appointed David Shapiro as a director, increasing the size of its board to eight members.

Shapiro has served as the chief medical officer of Intercept Pharmaceuticals Inc. since November 2017.

Organovo is a biotech platform company providing 3D bioprint tissues with human functionality.